Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression

被引:297
作者
Chauveau, C
Rémy, S
Royer, PJ
Hill, M
Tanguy-Royer, S
Hubert, FX
Tesson, L
Brion, R
Beriou, G
Gregoire, M
Josien, R
Cuturi, MC
Anegon, I
机构
[1] CHRU Nantes, INSERM, U643, F-44093 Nantes, France
[2] ITERT, Nantes, France
[3] INSERM, U601, Nantes, France
关键词
D O I
10.1182/blood-2005-02-0494
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heme oxygenase-1 (HO-1) is an intracellular enzyme that degrades heme and inhibits immune responses and inflammation in vivo. In most cell types, HO-1 is inducible by inflammatory stimuli and oxidative stress. Here we demonstrate that human monocyte-derived immature dendritic cells (iDCs) and several but not all freshly isolated rat splenic DC subsets and rat bone marrow-derived iDCs, spontaneously express HO-1. HO-1 expression drastically decreases during human and rat DC maturation induced in vitro. In human tissues, iDCs also express HO-1, whereas mature DCs do not. Induction of HO-1 expression with cobalt protoporphyrin (CoPP) in human and rat DCs inhibits lipopolysaccharide (LPS)-induced phenotypic maturation and secretion of proinflammatory cytokines, resulting in the inhibition of alloreactive T-cell proliferation. CoPP-treated DCs, however, retain the ability to produce the anti-inflammatory cytokine interleukin 10 (IL-10). Reactive oxygen species induced by LIPS in DCs were inhibited by induction of HO-1. In conclusion, we identify, for the first time, the capacity of HO-1 to block maturation of DCs and to inhibit proinflammatory and allogeneic immune responses while preserving IL-10 production. This novel immune function for HO-1 may be of interest for the inhibition of immune responses in autoimmune diseases, transplantation, and other conditions involving activation of the immune system.
引用
收藏
页码:1694 / 1702
页数:9
相关论文
共 58 条
[1]   Therapeutic applications of human heme oxygenase gene transfer and gene therapy [J].
Abraham, NG .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (30) :2513-2524
[2]   Role of interleukin 10 in specific immunotherapy [J].
Akdis, CA ;
Blesken, T ;
Akdis, M ;
Wüthrich, B ;
Blaser, K .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :98-106
[3]   Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse [J].
Araujo, JA ;
Meng, LZ ;
Tward, AD ;
Hancock, WW ;
Zhai, Y ;
Lee, A ;
Ishikawa, K ;
Iyer, S ;
Buelow, R ;
Busuttil, RW ;
Shih, DM ;
Lusis, AJ ;
Kupiec-Weglinski, JW .
JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1572-1580
[4]   Controllers of the immune system and a new promise for immunotherapy [J].
Banchereau, J ;
Paczesny, S ;
Blanco, P ;
Bennett, L ;
Pascual, V ;
Fay, J ;
Palucka, AK .
IMMUNE MECHANISMS AND DISEASE, 2003, 987 :180-187
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   Generation of heme oxygenase-1-transgenic rats [J].
Braudeau, C ;
Bouchet, D ;
Toquet, C ;
Tesson, L ;
Ménoret, S ;
Iyer, S ;
Laboisse, C ;
Willis, D ;
Jarry, A ;
Buelow, R ;
Anegon, I ;
Chauveau, C .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 228 (05) :466-471
[7]   Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer [J].
Braudeau, C ;
Bouchet, D ;
Tesson, L ;
Iyer, S ;
Rémy, S ;
Buelow, R ;
Anegon, I ;
Chauveau, C .
GENE THERAPY, 2004, 11 (08) :701-710
[8]   Transcriptional activation of the H0-1 gene by lipopolysaccharide is mediated by 5′ distal enhancers:: Role of reactive oxygen intermediates and AP-1 [J].
Camhi, SL ;
Alam, J ;
Wiegand, GW ;
Chin, BY ;
Choi, AMK .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 18 (02) :226-234
[9]   Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection [J].
Chauveau, C ;
Bouchet, D ;
Roussel, JC ;
Mathieu, P ;
Braudeau, C ;
Renaudin, K ;
Tesson, L ;
Soulillou, JP ;
Iyer, S ;
Buelow, R ;
Anegon, I .
AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (07) :581-592
[10]   A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment [J].
de Saint-Vis, B ;
Vincent, J ;
Vandenabeele, S ;
Vanbervliet, B ;
Pin, JJ ;
Aït-Yahia, S ;
Patel, S ;
Mattei, MG ;
Banchereau, J ;
Zurawski, S ;
Davoust, J ;
Caux, C ;
Lebecque, S .
IMMUNITY, 1998, 9 (03) :325-336